Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Danshen (Salvia miltiorrhiza) is a traditional Chinese medicinal herb widely used for circulatory disorders. Its use for supporting or treating poor circulation is both historically rooted and increasingly supported by scientific research. Multiple preclinical and clinical studies have investigated its effects on cardiovascular and vascular health. The primary active compounds—tanshinones and salvianolic acids—exhibit antioxidant, anti-inflammatory, vasodilatory, and antithrombotic activities. These properties can enhance blood flow and reduce vascular resistance.

Clinical trials, particularly in China, have evaluated Danshen extracts for angina pectoris, atherosclerosis, and peripheral vascular disease, often showing improvements in microcirculation and reductions in symptoms. For example, a 2017 meta-analysis in Phytomedicine reviewed randomized controlled trials and found that Danshen preparations, alone or in combination with conventional therapy, provided benefits in chronic stable angina, improving clinical outcomes and blood flow markers. However, methodological limitations and variability in product formulations limit the strength of conclusions.

Although evidence is promising and mechanistic studies support its vascular benefits, high-quality, large-scale randomized controlled trials outside China are limited. Regulatory bodies such as the European Medicines Agency acknowledge traditional use but highlight the need for further robust data. In summary, while Danshen's use for poor circulation is strongly rooted in tradition, there is moderate scientific evidence supporting its efficacy for improving circulation-related conditions.

More about Danshen
More about Circulation (poor)

Other ingredients used for Circulation (poor)

Other health conditions supported by Danshen

Products containing Danshen